Alpha-1 Antitrypsin Deficiency Augmentation Therapy and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Overall Market Size
2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size: 2021 VS 2028
2.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in Global Market
3.2 Top Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies Ranked by Revenue
3.3 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Companies
3.4 Top 3 and Top 5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in Global Market
3.6.1 List of Global Tier 1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Markets, 2021 & 2028
4.1.2 Glassia
4.1.3 Aralast NP
4.1.4 Prolastin C
4.1.5 Others
4.2 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue & Forecasts
4.2.1 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2022
4.2.2 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2023-2028
4.2.3 By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue & Forecasts
5.2.1 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2022
5.2.2 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2023-2028
5.2.3 By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2021 & 2028
6.2 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue & Forecasts
6.2.1 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2022
6.2.2 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2023-2028
6.2.3 By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
6.3.2 US Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.3.3 Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.3.4 Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
6.4.2 Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4.3 France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4.4 U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4.5 Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4.6 Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.4.8 Benelux Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
6.5.2 China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.5.3 Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.5.4 South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.5.6 India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
6.6.2 Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.6.3 Argentina Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028
6.7.2 Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.7.3 Israel Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
6.7.5 UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Grifols
7.1.1 Grifols Corporate Summary
7.1.2 Grifols Business Overview
7.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
7.1.4 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
7.1.5 Grifols Key News
7.2 CSL
7.2.1 CSL Corporate Summary
7.2.2 CSL Business Overview
7.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
7.2.4 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
7.2.5 CSL Key News
7.3 Baxter
7.3.1 Baxter Corporate Summary
7.3.2 Baxter Business Overview
7.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
7.3.4 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
7.3.5 Baxter Key News
7.4 Kamada
7.4.1 Kamada Corporate Summary
7.4.2 Kamada Business Overview
7.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
7.4.4 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
7.4.5 Kamada Key News
7.5 Takeda
7.5.1 Takeda Corporate Summary
7.5.2 Takeda Business Overview
7.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
7.5.4 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
7.5.5 Takeda Key News
7.6 Abeona
7.6.1 Abeona Corporate Summary
7.6.2 Abeona Business Overview
7.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Major Product Offerings
7.6.4 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global Market (2017-2022)
7.6.5 Abeona Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Opportunities & Trends in Global Market
Table 2. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers in Global Market
Table 3. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints in Global Market
Table 4. Key Players of Alpha-1 Antitrypsin Deficiency Augmentation Therapy in Global Market
Table 5. Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Type
Table 9. List of Global Tier 1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Grifols Corporate Summary
Table 31. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
Table 32. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
Table 33. CSL Corporate Summary
Table 34. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
Table 35. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Baxter Corporate Summary
Table 37. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
Table 38. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Kamada Corporate Summary
Table 40. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
Table 41. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Corporate Summary
Table 43. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
Table 44. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Abeona Corporate Summary
Table 46. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Offerings
Table 47. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Segment by Type in 2021
Figure 2. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Segment by Application in 2021
Figure 3. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
Figure 8. By Type - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 12. US Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 24. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
